EGFR and cancer: Furthermore, the PI3K-AKT-dependent actions on motility may represent a generalized pathway in cancers with FAT1 overexpression, for example, as reported in high-grade gliomas whose invasiveness was dependent upon EGFR-AKT signaling 69.